From October 1 to 3, 2025 — Orveda takes the stage at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) Dubai, hosted at the Grand Hyatt Dubai. Recognized as one of the most influential gatherings in aesthetic medicine.
Through a dedicated scientific symposium and immersive exhibition booth, Orveda will unveil its latest biotech innovation: a skincare protocol co-created with aesthetic doctors to support the skin before and after aesthetic procedures.
"At Orveda, we believe biotechnology marks a new era in skincare performance. Our latest research focuses on senescence and exosomes as critical frontiers for skin rejuvenation. We develop biotech-powered solutions that go beyond soothing to actively heal and extend the skin’s youthful integrity — even for the most over-stimulated or post-procedure skins." — Dr Shimei Fan, Chief Scientific & Sustainability Officer, Coty
Orveda will headline a scientific symposium titled “The Future of Pre- & Post-Procedure Experience: How Biotechnologies Can Reduce Senescence Markers and Modulate Skin’s Healing Exosomes.”
The session will feature leading experts, including Dr. Shimei Fan, Chief Scientific & Sustainability Officer at Coty, and Dr. Hassan Galadari, Aesthetic Dermatologist and Scientific Director of AMWC Dubai.
Complementing the dialogue, Orveda will host a 36m² exhibition booth, where visitors can experience the brand’s two professional-grade skincare ranges:
- The Green Line – a core collection designed to stimulate the skin between procedures, enhancing resilience and radiance.
- The White Line – including the Regenosome Pre & Post-Procedure Kit, a biotech protocol co-developed with physicians to prepare and support skin healing before and after aesthetic treatments.
We are honored to participate in AMWC Dubai, one of the most renowned medical congresses in the world. This event marks a key milestone as we prepare for our brand's expansion across the Gulf region. Orveda was created to meet the highest expectations of both professionals and clients, and we are thrilled to start writing this next chapter in the Middle East." — Nicolas Vu, CEO & Co-Founder, Orveda.
Orveda’s unique positioning at the intersection of cutting-edge biotechnology, luxury sensoriality, and clinical credibility offers a compelling new solution for practitioners seeking to elevate both outcomes and customers experience.
Rooted in biotech innovation, senescence research, and luxury care protocols, Orveda’s mission is to provide high-performance skincare solutions tailored for HNWI individuals and the professionals who care for them.
From La Maison Orveda in Paris, New York, Shanghai, and soon in Dubai… to the scientific stages of AMWC, the brand continues to redefine skincare with formulas that heal not just treat — and combin clinical results with sensory excellence.
